Oura Files Confidentially for IPO Signaling Potential Public Debut for Smart Ring Maker IFB Industries Q4 Net Profit Doubles to Rs 4267 Crore Revenue Up 1233 How to Save Money on Gas and Diesel Ahead of Memorial Day Weekend Travel European Media Magnate Vincent Bollors Expanding Influence Sparks Debate on Democratic Safeguards Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Concerns Mount CNBCs Charitable Trust Trims Stock That Surged 46 in a Week 80 Since April NPWR Q1 2026 Earnings EPS Misses Estimates as Net Power Focuses on Commercial Deployment Camden Property Trust CPT Q1 2026 Earnings Strong EPS Beat Signals Resilient Multifamily Operations DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Immunic Inc IMUX Q1 2026 Earnings EPS Misses Estimates as Pipeline Progress Takes Center Stage First Internet Bancorp INBK Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Interest Income Pulmonx LUNG Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Edges Higher StableX Technologies SBLX Holds Steady at 31 Amid Low Volume Consolidation Sunstone Hotel Investors SHO Rises Over 2 Breaking Above Key Resistance Levels Goldman Sachs Holds Near Key Psychological Level Amid Modest Gains Delta Air Lines DAL Rallies 3 as Air Travel Demand Strengthens JELDWEN Holding JELD Edges Higher Approaching Key Resistance Level RBIs Surprise 25BasisPoint Rate Cut May Signal Shift in Policy Framework Nomura Suggests BZAI Q1 2026 Earnings NarrowerthanExpected Loss EPS Beat Signals Operational Progress Sachem Capital 8 Notes SCCG Edge Lower as Yield Considerations Weigh HNVR Q1 2026 Earnings Slight EPS Miss Amid Challenging Operating Environment MANH Q1 2026 Earnings Earnings Beat Driven by Strong Cloud Momentum LPX Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Ridgepost Capital Inc RPC Q1 2026 Earnings Slight EPS Beat Amid Mixed Signals Stock Slips PSTV Q1 2026 Earnings WiderthanExpected Loss Reflects Ongoing RD Investment Target Q1 2026 Earnings EPS of 171 Amid Mixed Consumer Environment Alaunos Therapeutics TCRT Q4 2023 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline